Bringing Medication-Free Options to Patients of Panic Disorders with Joe Perekupka and Dr. Robert Cuyler
PTSD affects 6.1-9.2% of the adult US population (Up To Date). Additionally, an estimated 4.7% of adults will experience a panic disorder in their lifetime (NIMH). Unfortunately, both disorders have high rates of becoming chronic and require difficult treatment programs and medications with adverse side effects.
On this episode of Highway to Health, David Kemp talks to Joe Perekupka, CEO of Freespira, and Dr. Robert Cuyler, Chief Clinical Officer of Freespira, to discuss mental health and the drive behind Freespira’s drug-free PTSD treatments.
Both guests apply habits to maintain mental wellness; they exercise their bodies to calm their minds. Dr. Cuyler distills it into “three ingredients, exercise, connection, and purpose. These are the three things that keep me grounded.” When treating trauma, depression, anxiety, panic disorders, and PTSD, a great deal of information is available on medication and exposure therapy. Unfortunately, each has massive downsides.
Dr. Cuyler noted, “the challenge is using treatments that are hard to tolerate.” Even when executed well, exposure therapy is challenging for a patient to complete. The guests cite a recent study that found that about half of the people admitted to exposure therapy studies did not finish the treatment.
The other common path—medication—has a broad spectrum of results. Drugs have varying degrees of effectiveness from person to person and take a long time to reach the desired effect. Medications also have a vast range of known and unknown side effects. “Once the patient stops these medications, there’s a huge relapse in their symptoms coming back again,” said Perekupka. These factors are critical for the founding of Freespira and its mission. Listen to the entire podcast now.
Latest
VC Investment Valuations Podcast
In this episode of The Alternative Edge, a Weaver: Beyond the Numbers Podcast, host Becky Reeder, an audit partner and co-leader of the alternative investments practice at Weaver, engages with Sindhu Rajesh, an Alternative Investment Services Partner with Weaver. They unpack the complexities of venture fund valuations, offering critical insights into industry dynamics and best […]
The Role of VR and AR in Attractions and Enterprise Applications
In this Pro AV Today soundbite from Dan O’Brien of HTC VIVE, the conversation centered on the significant role of Virtual Reality (VR) and Augmented Reality (AR) in attractions and enterprise applications. O’Brien highlighted the critical need for durable hardware design, tailored to withstand extensive use in location-based entertainment (LBE) operations. Unlike consumer-grade VR headsets, […]
Dear Matt: Are Projectors a Dying Technology?
Are projectors a dying technology? In today’s rapidly evolving landscape of display technology, one might assume that projectors could soon be a thing of the past. Not so fast, thinks Vistacom’s Director of Technology, Matt Boyer. In this Dear Matt segment, Boyer, a seasoned expert with over three decades in the AV industry, looks […]